seborrheic dermatitis
Information
- Disease name
- seborrheic dermatitis
- Disease ID
- DOID:8741
- Description
- "A dermatitis that is an inflammatory skin condition resulting in flaky, white to yellowish scales on oily areas such as the scalp or inside the ear, which is caused due to a combination of an over production of skin oil and irritation from a yeast Malassezia furfur. The symptoms include itching, skin lesions and scales, redness, plaques and hair loss." [url:http\://www.nlm.nih.gov/medlineplus/ency/article/000963.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00403559 | Completed | Phase 2 | A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis | May 7, 2007 | February 27, 2009 |
| NCT00565279 | Completed | Phase 3 | Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis | December 2007 | June 2008 |
| NCT03567980 | Completed | Phase 4 | A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis | September 1, 2018 | May 12, 2021 |
| NCT03807453 | Completed | Comparison of Scalp Microbiota of the Psoriasis and Seborrheic Dermatitis Patients | April 25, 2019 | June 18, 2019 | |
| NCT04091646 | Completed | Phase 2 | Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis | December 4, 2019 | August 21, 2020 |
| NCT04445987 | Completed | Phase 2 | Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis | June 12, 2020 | November 19, 2022 |
| NCT04472546 | Completed | N/A | Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis | December 13, 2019 | February 2, 2024 |
| NCT04973228 | Completed | Phase 3 | Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM) | July 8, 2021 | April 6, 2022 |
| NCT05105139 | Completed | Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp | November 29, 2021 | February 25, 2022 | |
| NCT05787860 | Completed | Phase 2 | Ruxolitinib in Seborrheic Dermatitis | November 15, 2022 | January 26, 2024 |
| NCT00830908 | Completed | N/A | HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis | January 2009 | September 2009 |
| NCT00991198 | Completed | Phase 2 | The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage | September 2009 | January 2010 |
| NCT01203189 | Completed | N/A | Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo | September 2010 | June 2013 |
| NCT01591070 | Completed | Phase 4 | Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis | November 2010 | May 2011 |
| NCT01703793 | Completed | Phase 2 | Safety and Efficacy Study in Subjects With Seborrheic Dermatitis | September 2012 | January 2013 |
| NCT02349854 | Completed | Neurobiology of the Scalp in Seborrheic Dermatitis | February 2013 | July 2014 | |
| NCT02656368 | Completed | N/A | Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis | January 2015 | December 2015 |
| NCT02749383 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis | February 2014 | October 2015 |
| NCT03114111 | Completed | Early Phase 1 | Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis | January 2017 | December 4, 2019 |
| NCT05942248 | Recruiting | N/A | The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis | June 6, 2023 | April 6, 2024 |
| NCT06013371 | Recruiting | Phase 2 | PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea | June 30, 2023 | December 31, 2024 |
| NCT05319444 | Recruiting | N/A | Cleansing Device for the Treatment of Scalp and Hair Conditions | June 30, 2022 | July 2024 |
| NCT01315951 | Terminated | N/A | Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation | March 2011 | March 2012 |
| NCT01139749 | Unknown status | Phase 4 | Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea | October 2011 | December 2012 |
| NCT01024374 | Unknown status | Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face | April 2010 | ||
| NCT00767546 | Unknown status | Phase 1 | Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients | May 2009 | August 2010 |
| NCT03688971 | Unknown status | Phase 2 | Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis | October 22, 2018 | December 2019 |
- Disase is a (Disease Ontology)
- DOID:2723
- Cross Reference ID (Disease Ontology)
- ICD10CM:L21
- Cross Reference ID (Disease Ontology)
- ICD9CM:690.1
- Cross Reference ID (Disease Ontology)
- MESH:D012628
- Cross Reference ID (Disease Ontology)
- NCI:C111888
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:156328004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0036508
- Exact Synonym (Disease Ontology)
- seborrhea
- Exact Synonym (Disease Ontology)
- Seborrhoeic dermatitis
- Exact Synonym (Disease Ontology)
- Seborrhoeic eczema
- Exact Synonym (Disease Ontology)
- SKIN SEBORRHEIC
- HPO alt_id (Human Phenotype Ontology)
- HP:0007562
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001051